Clinical trials for Fibromyalgia

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Fibromyalgia. For all clinical trials, go to clinical trials search

This list shows clinical trials for Fibromyalgia

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Fibromyalgia
Title Recruitment status Location
A 12-WEEK, OPEN-LABEL, SAFETY TRIAL OF PREGABALIN IN PATIENTS WITH FIBROMYALGIA - N/A Not Recruiting United Kingdom
A randomised, double-blind, placebo-controlled, parallel group study to investigate the safety and efficacy of controlled-release ropinirole (CR) (1-24mg) administered once daily for 12 weeks in subjects with fibromyalgia. Not Recruiting United Kingdom
A Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Xyrem® (sodium oxybate) in Subjects with Fibromyalgia Not Recruiting United Kingdom
A European Phase III, Multicentre, Double-blind, Randomised, Placebo-Controlled Monotherapy Study of Milnacipran for the Treatment of the Fibromyalgia Syndrome. - FMS Europe Not Recruiting United Kingdom
A randomised, double-blind, placebo-controlled, parallel group study to investigate the safety and efficacy of controlled-release ropinirole CR 1-24mg administered once daily for 12 weeks in subjects with fibromyalgia. Not Recruiting United Kingdom
A MULTI-CENTER, LONG TERM, OPEN-LABEL STUDY OF [S,S]-REBOXETINE (PNU-165442G) ADMINISTERED ONCE DAILY IN PATIENTS WITH FIBROMYALGIA Not Recruiting United Kingdom
Double blind trial which has 3 arms- Study drug (DS-5565), Placebo (substance with no therapeutic effect) and Active control . Safety and efficacy (produce desired effect) will be checked on subjects with pain associated with Fibromyalgia. Not Recruiting United Kingdom
A Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Xyrem® (sodium oxybate) in Subjects with Fibromyalgia Not Recruiting United Kingdom
A EUROPEAN PHASE III, MULTICENTRE, DOUBLE-BLIND, RANDOMISED, MONOTHERAPY, 12-MONTH STUDY OF MILNACIPRAN FOR THE TREATMENT OF THE FIBROMYALGIA SYNDROME - FMS European Long-Term Study Not Recruiting United Kingdom
A 14 WEEK, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PREGABALIN TWICE DAILY IN PATIENTS WITH FIBROMYALGIA Not Recruiting United Kingdom

Page last reviewed: 01/03/2016

Next review due: 01/03/2019